The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peptide Therapeutics Drugs Market Research Report 2025

Global Peptide Therapeutics Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1987347

No of Pages : 98

Ask Your Query

Synopsis

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

The global Peptide Therapeutics Drugs market was valued at US$ 34550 million in 2023 and is anticipated to reach US$ 63940 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics Drugs.

Report Scope

The Peptide Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Sanofi
  • Eli Lilly
  • Novo Nordisk
  • Takeda
  • Teva
  • Novartis
  • AstraZeneca
  • Ipsen
  • AbbVie
  • Allergan
  • Ferring
  • Merck
  • JNJ
  • Tarix Pharmaceuticals
  • Lonza

Segment by Type

  • Injection
  • Oral
  • Other

Segment by Application

  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Drugs Market Perspective (2019-2030)
2.2 Peptide Therapeutics Drugs Growth Trends by Region
2.2.1 Global Peptide Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Therapeutics Drugs Historic Market Size by Region (2019-2024)
2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Region (2025-2030)
2.3 Peptide Therapeutics Drugs Market Dynamics
2.3.1 Peptide Therapeutics Drugs Industry Trends
2.3.2 Peptide Therapeutics Drugs Market Drivers
2.3.3 Peptide Therapeutics Drugs Market Challenges
2.3.4 Peptide Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Drugs Players by Revenue
3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2019-2024)
3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue
3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2023
3.5 Peptide Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Peptide Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Therapeutics Drugs Breakdown Data by Type
4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2019-2024)
4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2025-2030)
5 Peptide Therapeutics Drugs Breakdown Data by Application
5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2019-2024)
5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Therapeutics Drugs Market Size (2019-2030)
6.2 North America Peptide Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Therapeutics Drugs Market Size by Country (2019-2024)
6.4 North America Peptide Therapeutics Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Therapeutics Drugs Market Size (2019-2030)
7.2 Europe Peptide Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Therapeutics Drugs Market Size by Country (2019-2024)
7.4 Europe Peptide Therapeutics Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2019-2030)
8.2 Asia-Pacific Peptide Therapeutics Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Therapeutics Drugs Market Size (2019-2030)
9.2 Latin America Peptide Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Therapeutics Drugs Market Size by Country (2019-2024)
9.4 Latin America Peptide Therapeutics Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2019-2030)
10.2 Middle East & Africa Peptide Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction
11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.2.5 Eli Lilly Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Drugs Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Peptide Therapeutics Drugs Introduction
11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Peptide Therapeutics Drugs Introduction
11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Ipsen
11.8.1 Ipsen Company Detail
11.8.2 Ipsen Business Overview
11.8.3 Ipsen Peptide Therapeutics Drugs Introduction
11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.8.5 Ipsen Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Detail
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Peptide Therapeutics Drugs Introduction
11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.9.5 AbbVie Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Peptide Therapeutics Drugs Introduction
11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.10.5 Allergan Recent Development
11.11 Ferring
11.11.1 Ferring Company Detail
11.11.2 Ferring Business Overview
11.11.3 Ferring Peptide Therapeutics Drugs Introduction
11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.11.5 Ferring Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Peptide Therapeutics Drugs Introduction
11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.12.5 Merck Recent Development
11.13 JNJ
11.13.1 JNJ Company Detail
11.13.2 JNJ Business Overview
11.13.3 JNJ Peptide Therapeutics Drugs Introduction
11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.13.5 JNJ Recent Development
11.14 Tarix Pharmaceuticals
11.14.1 Tarix Pharmaceuticals Company Detail
11.14.2 Tarix Pharmaceuticals Business Overview
11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction
11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.14.5 Tarix Pharmaceuticals Recent Development
11.15 Lonza
11.15.1 Lonza Company Detail
11.15.2 Lonza Business Overview
11.15.3 Lonza Peptide Therapeutics Drugs Introduction
11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2019-2024)
11.15.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Peptide Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Peptide Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Peptide Therapeutics Drugs Market Share by Region (2019-2024)
Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Peptide Therapeutics Drugs Market Share by Region (2025-2030)
Table 11. Peptide Therapeutics Drugs Market Trends
Table 12. Peptide Therapeutics Drugs Market Drivers
Table 13. Peptide Therapeutics Drugs Market Challenges
Table 14. Peptide Therapeutics Drugs Market Restraints
Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2019-2024)
Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2023)
Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service
Table 22. Date of Enter into Peptide Therapeutics Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Peptide Therapeutics Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Peptide Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Peptide Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Peptide Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Peptide Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Peptide Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Peptide Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Peptide Therapeutics Drugs Product
Table 50. Sanofi Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Peptide Therapeutics Drugs Product
Table 55. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Novo Nordisk Company Detail
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Peptide Therapeutics Drugs Product
Table 60. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Peptide Therapeutics Drugs Product
Table 65. Takeda Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Teva Company Detail
Table 68. Teva Business Overview
Table 69. Teva Peptide Therapeutics Drugs Product
Table 70. Teva Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Peptide Therapeutics Drugs Product
Table 75. Novartis Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Peptide Therapeutics Drugs Product
Table 80. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Ipsen Company Detail
Table 83. Ipsen Business Overview
Table 84. Ipsen Peptide Therapeutics Drugs Product
Table 85. Ipsen Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 86. Ipsen Recent Development
Table 87. AbbVie Company Detail
Table 88. AbbVie Business Overview
Table 89. AbbVie Peptide Therapeutics Drugs Product
Table 90. AbbVie Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 91. AbbVie Recent Development
Table 92. Allergan Company Detail
Table 93. Allergan Business Overview
Table 94. Allergan Peptide Therapeutics Drugs Product
Table 95. Allergan Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 96. Allergan Recent Development
Table 97. Ferring Company Detail
Table 98. Ferring Business Overview
Table 99. Ferring Peptide Therapeutics Drugs Product
Table 100. Ferring Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 101. Ferring Recent Development
Table 102. Merck Company Detail
Table 103. Merck Business Overview
Table 104. Merck Peptide Therapeutics Drugs Product
Table 105. Merck Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 106. Merck Recent Development
Table 107. JNJ Company Detail
Table 108. JNJ Business Overview
Table 109. JNJ Peptide Therapeutics Drugs Product
Table 110. JNJ Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 111. JNJ Recent Development
Table 112. Tarix Pharmaceuticals Company Detail
Table 113. Tarix Pharmaceuticals Business Overview
Table 114. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product
Table 115. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 116. Tarix Pharmaceuticals Recent Development
Table 117. Lonza Company Detail
Table 118. Lonza Business Overview
Table 119. Lonza Peptide Therapeutics Drugs Product
Table 120. Lonza Revenue in Peptide Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 121. Lonza Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Therapeutics Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Peptide Therapeutics Drugs Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide Therapeutics Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Peptide Therapeutics Drugs Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Metabolic Disorders Case Studies
Figure 10. Central Nervous System Case Studies
Figure 11. Other Case Studies
Figure 12. Peptide Therapeutics Drugs Report Years Considered
Figure 13. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Peptide Therapeutics Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Peptide Therapeutics Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Peptide Therapeutics Drugs Market Share by Players in 2023
Figure 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2023
Figure 19. North America Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Peptide Therapeutics Drugs Market Share by Country (2019-2030)
Figure 21. United States Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Peptide Therapeutics Drugs Market Share by Country (2019-2030)
Figure 25. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2019-2030)
Figure 33. China Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Peptide Therapeutics Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 48. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 49. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 50. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 51. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 54. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 55. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 56. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 57. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 58. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 59. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 60. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 61. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock